REVUMENIB for Leukaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where REVUMENIB was used for Leukaemia.
Most Reported Side Effects for REVUMENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 57 | 15.4% | 2 | 2 |
| Platelet count decreased | 50 | 13.5% | 2 | 19 |
| Nausea | 49 | 13.2% | 1 | 13 |
| Product dose omission issue | 40 | 10.8% | 2 | 17 |
| Death | 38 | 10.2% | 38 | 6 |
| Vomiting | 26 | 7.0% | 1 | 9 |
| Fatigue | 24 | 6.5% | 0 | 11 |
| Pyrexia | 22 | 5.9% | 3 | 14 |
| Differentiation syndrome | 16 | 4.3% | 3 | 4 |
| Haemoglobin decreased | 16 | 4.3% | 2 | 8 |
| White blood cell count decreased | 16 | 4.3% | 0 | 5 |
| Diarrhoea | 15 | 4.0% | 0 | 4 |
| Disease progression | 15 | 4.0% | 4 | 4 |
| Drug ineffective | 15 | 4.0% | 2 | 4 |
| Neutrophil count decreased | 15 | 4.0% | 1 | 2 |
Other Indications for REVUMENIB
Acute myeloid leukaemia (227)
Product used for unknown indication (87)
Acute lymphocytic leukaemia (13)
Acute myeloid leukaemia refractory (7)
Acute leukaemia (6)
Other Drugs Used for Leukaemia
DASATINIB (654)
VENETOCLAX (307)
CYTARABINE (288)
METHOTREXATE (282)
IMATINIB (281)
RUXOLITINIB (230)
NILOTINIB (203)
BOSUTINIB (191)
VINCRISTINE (172)
CYCLOPHOSPHAMIDE (153)